D Zhang, J Xie, F Sun, R Xu, W Liu, J Xu, X Huang… - Cancer Letters, 2024 - Elsevier
Immunotherapy aimed at inhibiting the negative co-stimulatory molecule programmed cell
death-ligand 1 (PD-L1) has limited effectiveness, with clinical response rates remaining …